{"name":"Rakuten Medical, Inc.","slug":"rakuten-medical-inc","ticker":"","exchange":"","domain":"rakutenmedical.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Physician's Choice SOC","genericName":"Physician's Choice SOC","slug":"physician-s-choice-soc","indication":"Locally advanced or metastatic solid tumors (Phase 3 development)","status":"phase_3"}]}],"pipeline":[{"name":"Physician's Choice SOC","genericName":"Physician's Choice SOC","slug":"physician-s-choice-soc","phase":"phase_3","mechanism":"Physician's Choice SOC is an X-ray activated photodynamic therapy agent that generates reactive oxygen species upon X-ray irradiation to destroy cancer cells.","indications":["Locally advanced or metastatic solid tumors (Phase 3 development)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxOUjkwa2piX1NPZjNKelBxRTgxaFI5UUxON2llM00xb3lUTHBSa2VJZUYwM0FNNTMxX3RiNE00a0RsSFpMa1hORkt4M1Q1X2RPV0VXVGlaZjZ3ZVdxR2c1bF9QT0poM01iWUJLS0RTQWsteDZkYWhqLW5zUTBFUWJpTUlUMkIzaGJVMlVnVlJmYjNHWG1ZRGcteUNZQm00dw?oc=5","date":"2026-03-20","type":"pipeline","source":"openPR.com","summary":"Cutaneous Squamous Cell Carcinoma Pipeline Grows as 45+ Pharma - openPR.com","headline":"Cutaneous Squamous Cell Carcinoma Pipeline Grows as 45+ Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTE1zQmpNeEJSeEJ5QjFMbW0waXFNZmV2Tm94eklOWWdIZGNjNURvMkVURkJ0ZzR2emZvRzZfazVtd2ljcHJWaUtUWGp1a2w2akhMX3NmUGlQSFN0elB6WDR3cW9JblE5REo2bk40TDAtVWE?oc=5","date":"2026-01-20","type":"pipeline","source":"Rakuten Medical","summary":"Rakuten Medical Expands Academic Access to IR700 Dye Through Fee-Only Provision, Greater Publication Freedom and Expanded IP & Commercialization Opportunities - Rakuten Medical","headline":"Rakuten Medical Expands Academic Access to IR700 Dye Through Fee-Only Provision, Greater Publication Freedom and Expande","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxQdHJILXJKZ3FlN3k0Qmd4bEs2cW9sTFpta3hvSnI4Ui0yWWFfN1JUU2hCWmpqZGdmVG1DNFY0dWRDQVVkRVRadjltX0ZVV2ZaemE4SkdiaTJIVk1FbVRRWWpod3d4REtqRjBDcEwxVThYZ0RySk9qOFhxTXlGbmxoT2ZVdWF5ellfUGJidmVBQ0x3Y3Z1RWR4eHBkWVhpSmJ1RWdvdg?oc=5","date":"2026-01-20","type":"pipeline","source":"BioWorld News","summary":"Rakuten closes $100M series F round, teams with Lotte Biologics - BioWorld News","headline":"Rakuten closes $100M series F round, teams with Lotte Biologics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAJBVV95cUxPWDhRelFoNmVVZzhKODB2M3g4bmdIeVVkSDJYZUhIbHlkZVlSdUtlWjJ1dFJDRDlWR3lueWdFQkstYlVlUW5BOWdkVzhaVlJqY2JTVEhRNzhucmJMam1yZFVkdVpEazEwUm0td0drYnBOLTVWQVZwYlUxYlZST0RaNjBwY2ZrZFh2OTI0dm5HY2Zoa0I2VzhNNE54aGdBTnZ5SVVBWWlwbWRRaGpoYmFVXzNvcm84RmNRTUFGaG5CNHQyV2YwXzV1SHYxUmtBTUl5STVMNU00MmIxUEloZW9ITWtaOU5JRUVjSlhRMXBOMnNwWFpiUHBPTkdWNjMzY2RoQ3ZGeksxMUY?oc=5","date":"2026-01-13","type":"pipeline","source":"PR Newswire","summary":"Rakuten Medical and LOTTE Biologics Sign Manufacturing Agreement to Support Biopharmaceuticals in Global Oncology Program - PR Newswire","headline":"Rakuten Medical and LOTTE Biologics Sign Manufacturing Agreement to Support Biopharmaceuticals in Global Oncology Progra","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxOZWo1NmdNdWpzRVdscGYtR2hyclQ5b2VQelF0Wnd1b3RPY1Q0TnN1dDhEczhkbklCRlJqVmFlRXkzOWFrLUNSaTFUN0ZjUGw2SlhwbTFlZnZ6aFg4UlVXTkxyUXJhTUNwb1UtelJQcV9EQWVWODJNLW1jbk0wb0FCYjFGX2hsREFDeWgwN2pTYjhQVW9IbE51dllMcERaMHM?oc=5","date":"2026-01-08","type":"pipeline","source":"WSJ","summary":"Rakuten Medical Raises $100 Million in Fundraising Round - WSJ","headline":"Rakuten Medical Raises $100 Million in Fundraising Round","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTFByU3pzRkwyb3F5QllvT3RFTW1SN1NteURnTUU5cFhVYXJzTEREVWZOeVB0UXNxUzRoa1F4VzBvWkZXOERGNFZodFRHd1BKQTJ2MG9ZZndjUHJuZi1CWFFOY1c1aXotUEx1TzM1U2NJeGg?oc=5","date":"2026-01-07","type":"regulatory","source":"Rakuten Medical","summary":"Rakuten Medical Raises $100 Million in Oversubscribed Series F to Accelerate Development Toward U.S. Regulatory Approval - Rakuten Medical","headline":"Rakuten Medical Raises $100 Million in Oversubscribed Series F to Accelerate Development Toward U.S. Regulatory Approval","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTFAyaE9kRlAzUTd2a05kQ2tuLVY0cnllOFNWUnd4WG9DaTJ0MmRvblJ5dzl0UjBYSXRDcnNWYThNMjJ4LXhRaXc5TlJ6X0pKR0pUUnAzQ3hUSm5wSHU1alFHQi01TWVQWEREYm84VUtPaVY?oc=5","date":"2025-12-18","type":"pipeline","source":"Rakuten Medical","summary":"Rakuten Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 15th, 2026 - Rakuten Medical","headline":"Rakuten Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 15th, 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTE5vQWJtWERrLWRrMjdZcWNSMXJTenNHeHdmVjFPNmo0MDAwTVpiS291bmZQYm5GS2xaLVpBclFyZXZ2WWl4ZXA2amt1VC1hcERZdFZCWlRpQjNOUWFia1pHN2VPQUxUOGpkeXkwX21qaVo?oc=5","date":"2025-11-10","type":"pipeline","source":"Rakuten Medical","summary":"Rakuten Medical Presents Poster at SITC 2025 Reporting Immune Activation in Operable HNSCC and cuSCC Treated with ASP-1929 Photoimmunotherapy Prior to Surgery - Rakuten Medical","headline":"Rakuten Medical Presents Poster at SITC 2025 Reporting Immune Activation in Operable HNSCC and cuSCC Treated with ASP-19","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxPWnUtUzhKZEtERDYtNlVRcHlJRGhrR3RiU3h6TnpNSVFoOC11MUMxakloMEZkTVEtRDZ6VFE1UGM2U3ktYXVDRGVXQ0VmVjVwRDY2Umd1cVlObG5VSjB2S0dkdW95Q1N6SS1QTVBVbl95eVN5RnpEUXpRU2RSb3ZLaHVrVmpLMWFpbkxjWm1NVDNhUnY0c2JRc2tRX29hck5naDR0bzBjY2laMXFo?oc=5","date":"2025-09-26","type":"trial","source":"BioWorld News","summary":"Real-world data illuminates Rakuten's Alluminox solid tumor platform - BioWorld News","headline":"Real-world data illuminates Rakuten's Alluminox solid tumor platform","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxQbkYzLXExcU92akc3VE9wcDBKR1JwdHB2ellSR2t6Rjh6RWRWRmNyWG94d2RMVjVOdUNKMHNmb0hYTjQ4b3YyUWExQjFGaS1vWW8wQTlXRUppamowU1EwMHNMSkNTa3dMMDlIMVVRVkc2T3hLZDh0Z0FlRUtORkdFNi1ZaU0wUHZUdVQxOHJlOWVydVFRNDdNODNuYWRMMkp1cm1r?oc=5","date":"2025-09-12","type":"pipeline","source":"WSJ","summary":"Rakuten Medical to Weigh IPO to Extend Funding Beyond 2027 - WSJ","headline":"Rakuten Medical to Weigh IPO to Extend Funding Beyond 2027","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTE9xSTBmOXhtS1ZuR1BLQWxsanB1SWpZXzBFQm9qS0lJM3BjVFJaYk9uY3NhS29peWxablRreVFYWUIzYXhlel9tZW1LaXdodjd6UmdXc2hFYzF0NzFHTzBScDZxalpSVXB0cXo0cWVRYTE?oc=5","date":"2025-07-28","type":"trial","source":"Rakuten Medical","summary":"Rakuten Medical Expands Patient Recruitment to Japan and Prepares for Expansion to Eastern Europe in Global Phase 3 Trial of ASP-1929 Photoimmunotherapy Combined with Pembrolizumab for 1L Recurrent He","headline":"Rakuten Medical Expands Patient Recruitment to Japan and Prepares for Expansion to Eastern Europe in Global Phase 3 Tria","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTE9wQ0hlMjVZYlZtSGxNM3o4U1BYN0VTbFMzYm5UVFJnZDhMblVNYnZsZzRsUUtNdl9BellRYWdDejhKWXE4MzJQVmR2clV0VDNVdUFQamZVOVVXZmlhT21Dak9QNmt1UWNmSXhNcFY4dHE?oc=5","date":"2025-06-23","type":"pipeline","source":"Rakuten Medical","summary":"Rakuten Medical Strengthens Executive Team with Appointment of CFO Andrew Liu - Rakuten Medical","headline":"Rakuten Medical Strengthens Executive Team with Appointment of CFO Andrew Liu","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}